In terms of tumor therapy, some studies have shown that overexpression of FLT3LG can induce the expansion of tumor-infiltrating DCs30, 31; FLT3/FLT3LG enhanced the immune response of DCs to malignant tumors by promoting their differentiation27, 28. The gene discussed is FLT3LG; the disease is cancer.